Published experimental works focus on their effects on endothelin-1 (Tsai et al. 2015) and endothelin receptors (Chen et al. 2013; Uddin et al. 2019), but little is known about endothelin-3, particularly in endometrial cancer. The gene discussed is EDN1; the disease is endometrial cancer.